The pharmaceutical company "Pfizer Inc." announced its intention to release an over-the-counter form of the drug for the treatment of erectile dysfunction Viagra/Viagra (sildenafil citrate). Interest in increasing sales of Viagra is dictated by high competition with similar drugs Cialis/Cialis (tadalafil) and Levitra/Levitra (vardenafil).

This step will require some changes — it may be necessary to reduce the dosage of the active substance. In addition, the new form of the drug will be sold at a lower price, as well as other means of over-the-counter group.

Analysts doubt that the us Food and Drug administration (FDA) will issue a marketing authorization for over the counter viagra substitute the review can be found here , since it is known that the drug has a number of severe adverse reactions, such as sudden vision loss, priapism, and is incompatible with nitrates.

All identified adverse reactions and possible complications from taking Viagra are indicated in the instructions, but opponents of the release of an over-the-counter form of Viagra believe that it is impossible to give the decision to use such a tool to a simple consumer who does not always pay attention to the warnings of the leaflet.

In turn, "Pfizer Inc." notes that Viagra is not a treatment for any serious disease, and its choice can be entrusted to the patient.

Students and Alumni




  • No events